about
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is ...
Read More
125.70
-5.46
(-4.16%)
949.7K
XNAS Volume
XNAS 24 Jul, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Abivax (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..